FIELD: organic chemistry, heterocyclic compounds, biochemistry. SUBSTANCE: products: new derivatives of pyrazolo-[4,3-d]-pyrimidine-7-one of the formula (I) where R1 - H, CH3,C2H5; R2 - CH3,CH2OH,CH2OCH3 or n-C3H7; R3 - C2H5, CH2=CH-CH2; R4 together with nitrogen atom to which it is bound forms 4-R5-piperidino- or 4-N-(R6)-piperazyl group; R5 - H, N-(CH3)2,CONH2; R6 - H, CH3, i-C3H7,CH2CH2OH,CSNH2,C(NH)NHCH3 or C(NH)S-CH3, and their pharmaceutically acceptable salts. Invention relates to also pharmaceutical composition showing inhibitory activity with respect to cyclic guanosine-3',5'-monophosphate phosphodiesterase that has 1-400 mg of compound of the formula (I) per a single dose in mixture with pharmaceutically acceptable vehicle or carrier. Invention relates to also a method of treatment or prophylaxis of states caused by phosphodiesterase activity by prescription to human an effective dose of compound of the formula (I) or its pharmaceutically acceptable salt of above indicated composition. Invention relates to also intermediate compounds of formulas (II) and (IV) where R1,R2,R3 have values given above. In compounds of the formula (II) radical R3 can mean atom H and Y - atom Cl. EFFECT: improved method of synthesis of new compounds, enhanced effectiveness. 9 cl, 2 tbl
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF PYRAZOLOPYRIMIDINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1991 |
- Ehndrju Sajmon Bell[Gb]
- Dehvid Braun[Gb]
- Nikolas Kennet Terrett[Gb]
|
RU2047617C1 |
PYRAZOLOPYRIMIDINONES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF CYCLIC GUANOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE |
1992 |
- Ehndrju Simon Bell
- Nikolas Kennet Terrett
|
RU2114113C1 |
PYRAZOLEPYRIMIDINONES FOR TREATMENT OF IMPOTENTS |
1994 |
- Piter Ehllis
- Nikolas Kennet Terrett
|
RU2130776C1 |
IMPROVED METHOD FOR PREPARING 5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-N-PROPYL-1, 6-DIHYDRO-7H-PYRAZIL[4,3-D]PYRIMIDINE-7-ONE |
2003 |
- Modi Shirish Bkhagvanlal
- Doshi Madkhukant Mansukkhlal
- Shrikande Atul Anant
|
RU2239637C1 |
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
|
RU2124016C1 |
PYRIDINE DERIVATIVES CONDENSED WITH HETEROCYCLE |
1996 |
- Li Daniel Arnol'D
- Mikel Pol Mojer
- S'Juzan Bet Sobolov-Dzhejniz
|
RU2136683C1 |
PIRAZILE PYRIMIDINONES FOR IMPOTENCY TREATMENT |
1994 |
- Ehllis Piter
- Terrett Nikolas Kennet
|
RU2373938C9 |
TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING |
1996 |
- Allen Jakob Daplehntir
- Kelvin Kuper
|
RU2161158C2 |
DERIVATIVES OF PYRROLO[2,3-D]PYRIMIDINES, PHARMACEUTICAL COMPOSITION, PYRROLO[2,3-D]PYRIMIDINES, DERIVATIVES OF PYRROLE |
1993 |
|
RU2124015C1 |
PROCESS FOR PREPARING SUBSTITUTED N-(5-TETRASOLYL)-1-KETO-1H-TRIAZOLE (3,2-ALPHA) PYRIMIDINE-2-CARBOXAMIDES OR THEIR SALTS (MODIFICATIONS) |
0 |
|
SU1042620A3 |